The Retinoic Acid Receptor as a target for drug and gene therapy for degenerative blinding disorders

9^th September 2019, 14h00 - 15h00
(Salle de Conference du RDC de l'UCL, 13 rue Moreau)

Richard H Kramer (Professor of Neurobiology and Vision Science, Berkley University of California)

https://vcresearch.berkeley.edu/faculty/richard-h-kramer

Invited by Serge Picaud

The Retinoic Acid Receptor as a target for drug and gene therapy for degenerative blinding disorders Retour